The Work We Fund

Funded projects
Men's Health Partners
"We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact." - Owen Sharp, CEO
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“We’re alarmed by the increasing number of men who take their own lives around the world. We are working to ensure all men and boys look after their mental health and are comfortable to reach out to others for support when they’re struggling.” 
Craig Martin, Global Director - Mental Health & Suicide Prevention programs
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

Swiss Prostate Cancer Award - PEACE V: A randomized phase III trial for the Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)

Movember Funding to Date

EUR 200,000

What we seek to achieve

Dr. Thomas Zilli from Geneva University Hospital will conduct an important multi-centre trial which aims to compare two different radiotherapy techniques in nodal-recurrent prostate cancer patients and determine which is more efficient in slowing the progression of their cancer.

Implemented by
Movember Foundation
Project start date
November 2016
Project Status
In Progress

About the project

This clinical trial will improve our insights in the pattern of recurrence following different treatment modalities with the expectation that prophylactic whole pelvic radiotherapy will reduce the number of nodal relapses, thereby improving progression-free survival and postponing the need for palliative systemic treatments while maintaining quality-of-life of prostate cancer patients. This phase III clinical trial will try to establish a golden standard in the treatment of oligorecurrent nodal prostate cancer.

This research project underwent a peer review process involving a panel of experts in clinical and translational research across the prostate cancer field.

Page 1 of 22